Daily Bulletin

The Times Real Estate

.

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
LumaCina announces availability of Oral Morphine pain medication for New Zealanders

PERTH, Australia and MIAMI, May 31, 2024 /PRNewswire/ -- LumaCina, the pharmaceutical supplier and marketing division of Bridgewest Perth Pharma announce new production of Oral Morphine to meet critical drug shortage in New Zealand.

The shortfall of Oral Morphine has become increasingly concerning in New Zealand, adversely affecting patients who rely on this medication to manage pain effectively. Recognizing the gravity of the situation, LumaCina has been actively working in partnership with Pharmac, New Zealand's government agency responsible for pharmaceutical funding and access, to bridge the supply gap. LumaCina has made substantial investments to expand capabilities for steady supply of Oral Morphine.

"We are deeply committed to addressing the shortage of Oral Morphine and ensuring that patients have access to the medication they need to alleviate pain and improve their quality of life," said Cyrus K. Mirsaidi, Global CEO for LumaCina and Bridgewest Perth Pharma. "Through our collaboration with Pharmac, we are leveraging our collective expertise and resources to make a meaningful difference in the lives of patients across New Zealand."

"Making a positive impact on public health is paramount to our group's efforts. Through our ingenuity and resources, we aim to make a significant and lasting impact on the healthcare landscape and the lives of all," said Dr. Masood Tayebi, CEO and Founding Partner of global private equity firm, Bridgewest Group.

Last year, Bridgewest Group made a key strategic move to broaden its life science ecosystem, expanding capabilities throughout research and development, manufacturing, and delivery. It acquired the Pfizer Perth cGMP sterile injectable manufacturing plant, and formed Bridgewest Perth Pharma, NovaCina CDMO division and LumaCina pharmaceutical supply division.

About LumaCina

LumaCina is a global supplier and marketer of sterile injectable pharmaceutical drugs located in Perth Australia. LumaCina is aggressively expanding capabilities, infrastructure, and industry partnerships, growing a robust pipeline of high-quality accessible injectable medications, spanning high potency, blow fill seal, multi format vials and more. LumaCina is a Bridgewest Group Portfolio Company.

Media Contact: Jenny Bourbiel, jbourbiel@bridgewestgroup.com

Logo - https://mma.prnasia.com/media2/2425397/LumaCina_Logo.jpg?p=medium600

Authors: PR Newswire Asia - Daily Bulletin Au RSS

Read more https://www.prnasia.com/story/archive/4426743_AE26743_0

Business News

How to Estimate the Right Skip Bin Size for Your Renovation Project

One of the most challenging aspects of planning a renovation project is estimating the amount of waste you'll generate. Choosing a skip bin that's too small means paying for additional bins or picku...

Daily Bulletin - avatar Daily Bulletin

Cool Room Hire: The Ultimate Solution for Temperature-Sensitive Storage

Businesses in the food, pharmaceutical, and event industries often require reliable refrigeration to keep products fresh and safe. Cool room hire provides a flexible and cost-effective solution for ...

Daily Bulletin - avatar Daily Bulletin

Thryv Australia named global winner of the 2025 Microsoft Advertising Partner Awards

Melbourne – 11 March 2025:   Thryv® (NASDAQ: THRY), provider of the leading small business marketing and sales software platform, has been named the global winner of the Microsoft Advertising Part...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals